Five new MDS drugs "set to launch by 2018" PharmaTimes Currently, there is only one curative treatment for MDS - allogeneic hematopoietic stem cell transplant (HSCT); however, because of old age and poor general performance status, around 75% of patients are classified as ineligible for this treatment ... |
